Ribavirin Pregnancy Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by INC Research
Sponsor:
Collaborators:
Aurobindo Pharma
Genentech, Inc.
Sandoz Inc.
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Kadmon Pharmaceuticals, LLC
Zydus Pharmaceuticals USA, Inc.
Information provided by (Responsible Party):
INC Research
ClinicalTrials.gov Identifier:
NCT00114712
First received: June 16, 2005
Last updated: March 30, 2015
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2027
  Estimated Primary Completion Date: November 2027 (Final data collection date for primary outcome measure)